Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Omeprazole Stories

2009-11-12 07:00:00

CINCINNATI, Nov. 12 /PRNewswire-FirstCall/ -- The National Football League, Prilosec OTC® and Pro-Football Hall-of-Fame Member John Madden announced today the creation of the first annual Madden Most Valuable Protectors Award presented by Prilosec OTC. The award will celebrate the important role linemen play in their team's success and honor the NFL's best offensive linemen based on their 2009 regular season performance. While most attention is typically focused on more...

2009-10-26 22:50:42

Helicobater pylori, a bacteria implicated in peptic ulcers and gastritis, was eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide (Alinia®) and doxycycline (LOAD) compared to eradication in only 80.9 percent of patients on lansoprazole, amoxicillin and clarithromycin (LAC) for seven days. Results of a new study presented at the Annual Scientific Meeting of the American College of Gastroenterology reveal...

2009-09-25 09:07:07

Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested. The results were presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the...

2009-08-18 07:30:00

HAIKOU CITY, China, Aug. 18 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections. Omeprazole is widely utilized to treat gastroesophageal reflux disease (GERD), and is highly effective...

2009-06-02 07:00:00

WILMINGTON, Del., June 2 /PRNewswire-FirstCall/ -- Two studies from AstraZeneca (NYSE: AZN) show that symptomatic gastroesophageal reflux disease (GERD) patients treated with NEXIUM(R) (esomeprazole magnesium) 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks(1). NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated with GERD. NEXIUM, in a class of drugs...

2009-05-22 08:00:00

PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE(R) (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC(R) 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated. In the same study, coadministration...

2009-05-14 15:30:00

CINCINNATI, May 14 /PRNewswire/ -- In response to the FDA's approval of Prevacid OTC(R) 24HR, The Procter & Gamble Company issued the following statement: (Photo: http://www.newscom.com/cgi-bin/prnh//NY17325 ) "Prilosec OTC(R) is the #1 doctor and pharmacist recommended over-the-counter heartburn remedy in the U.S.," said Tim Brown - General Manager, P&G Personal Health Care North America. "Procter & Gamble built the OTC PPI market and since 2003, millions of consumers have...

2009-05-07 08:47:52

Proton pump inhibitors interfere with anti-clotting protection of clopidogrel The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented yesterday at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual...

2009-05-06 23:39:13

The anti-clotting action of the medication clopidogrel -- Plavix -- can be compromised by common drugs for the treatment of heartburn, U.S. researchers said. Principal investigator Eric J. Stanek of Medco Health Solutions in Franklin Lakes, N.J., said the study specifically focused on the effects of proton pump inhibitors -- omeprazole or Prilosec; esomeprazole or Nexium; pantoprazole or Protonix; and lansoprazole or Prevacid. Together those drugs accounted for about 96 percent of proton...

2009-05-06 12:45:00

- Four of the most commonly used proton pump inhibitors raise risk of heart attack and stroke for patients taking Plavix(R) and increase healthcare costs - Drug interaction increases annual hospital costs by nearly 40 percent FRANKLIN LAKES, N.J., May 6 /PRNewswire-FirstCall/ -- Four of the most commonly prescribed heartburn medications reduce the benefit associated with clopidogrel, a widely used antiplatelet medication also known by its brand name, Plavix. These findings by researchers...